Protein A Resin Market, By Product, By Matrix Type, By Application (Immunoprecipitation, Antibody Purification), By End User, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Protein A is a bacterial protein, which has capacity to bind mammalian antibodies of class immunoglobulin G with great affinity. Protein G binds to all subclasses of human immunoglobulin G (IgG) makes it useful for purifying polyclonal or monoclonal IgG antibodies whose subclasses have not been determined. Monoclonal antibodies are defined as 'an antibody produced by a single clone of cells'. It can be used to carry drugs, toxins, or radioactive substances traditional to cancer cells. Monoclonal antibodies have been showing promising results in the management of chronic diseases such as cancers and rheumatoid arthritis. These are essential and are broadly used as purification and separation materials due to high resolution, across the biopharmaceutical industry. Natural protein A can be produced from Staphylococcus aureus, though protein A is now commonly produced recombinant in Escherichia coli. Chromatography with these has several advantages as a separation method, over conventional techniques such as solvent extraction, crystallization, and distillation.

Restraints of the Global Protein A Resin Market

Major factors hampering the growth of the protein A resin market during the forecast period constitutes of rise in alternate methods for purification of monoclonal antibodies.

Key features of the study:

• This report provides in-depth analysis of the global protein A resin market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021, as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
• It profiles leading players in the global protein A resin market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include GE Healthcare, Thermo Fisher Scientific, Repligen, Tosoh Bioscience, EMD Millipore, Novasep, GenScript Biotech Corporation, Purolite Life Sciences, and Expedeon Ltd.
• Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
• The global protein A resin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

• Global Protein A Resin Market, By Product:
  • Natural Protein A
  • Recombinant Protein A
• Global Protein A Resin Market, By Matrix Type:
  • Agarose-based
  • Glass or Silica Based
  • Organic Polymer Based
• Global Protein A Resin Market, By Application:
  • Immunoprecipitation (IP)
  • Antibody Purification
• Global Protein A Resin Market, By End User:
  • Biopharmaceutical Manufacturers
  • Clinical Research Laboratories
  • Academic Institutes
• Global Protein A Resin Market, By Geography:
  • North America
• By Product
  • Natural Protein A
  • Recombinant Protein A
• By Matrix Type
  • Agarose-based
  • Glass or Silica Based
  • Organic Polymer Based
• By Application
  • Immunoprecipitation (IP)
  • Antibody Purification
• By End User
  • Biopharmaceutical Manufacturers
  • Clinical Research Laboratories
  • Academic Institutes
• By Country:
  • U.S.
  • Canada
  • Europe
• By Product
  • Natural Protein A
  • Recombinant Protein A
• By Matrix Type
  • Agarose-based
  • Glass or Silica Based
  • Organic Polymer Based
• By Application
  • Immunoprecipitation (IP)
  • Antibody Purification
• By End User
  • Biopharmaceutical Manufacturers
  • Clinical Research Laboratories
  • Academic Institutes
• By Country:
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
• By Product
  • Natural Protein A
  • Recombinant Protein A
• By Matrix Type
  • Agarose-based
  • Glass or Silica Based
  • Organic Polymer Based
• By Application
  • Immunoprecipitation (IP)
  • Antibody Purification
• By End User
  • Biopharmaceutical Manufacturers
  • Clinical Research Laboratories
  • Academic Institutes
• By Country:
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
• By Product
  • Natural Protein A
  • Recombinant Protein A
• By Matrix Type
  • Agarose-based
  • Glass or Silica Based
  • Organic Polymer Based
• By Application
  • Immunoprecipitation (IP)
  • Antibody Purification
• By End User
  • Biopharmaceutical Manufacturers
  • Clinical Research Laboratories
  • Academic Institutes
• By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East:
• By Product
  • Natural Protein A
  • Recombinant Protein A
• By Matrix Type
  • Agarose-based
  • Glass or Silica Based
  • Organic Polymer Based
• By Application
  • Immunoprecipitation (IP)
  • Antibody Purification
• By End User
  • Biopharmaceutical Manufacturers
  • Clinical Research Laboratories
  • Academic Institutes
• By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
• By Product
  • Natural Protein A
  • Recombinant Protein A
• By Matrix Type
  • Agarose-based
  • Glass or Silica Based
  • Organic Polymer Based
• By Application
  • Immunoprecipitation (IP)
  • Antibody Purification
• By End User
  • Biopharmaceutical Manufacturers
  • Clinical Research Laboratories
  • Academic Institutes
• By Country/Region:
  • Central Africa
  • South Africa
  • North Africa
• Company Profiles
  • GE Healthcare*
• Company Overview
• Product Portfolio
• Financial Performance
• Key Strategies
• Recent Developments
  • Thermo Fisher Scientific
  • Repligen
  • Tosoh Bioscience
  • EMD Millipore
  • Novasep
  • GenScript Biotech Corporation
  • Purolite Life Sciences
  • Expedeon Ltd.
  • Other Players

"*" marked represents similar segmentation in other categories in the respective section.